West Pharmaceutical Services (BSP:W2ST34) Net Loan

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:W2ST34 West Pharmaceutical Services Inc BSP:W2ST34
24 GF Score
Price R$51.25
GF Value R$43.98
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is West Pharmaceutical Services Net Loan?

Net Loan only applies to banks and insurance companies.

BSP:W2ST34
24GF Score
West Pharmaceutical Services Inc BSP:W2ST34
Net Loan is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is West Pharmaceutical Services (BSP:W2ST34) Overvalued in 2026?

Based on GuruFocus' analysis, West Pharmaceutical Services stock appears to be overvalued. The current stock price of R$51.25 is trading 16.5% above its estimated GF Value™ of R$43.98. GuruFocus considers West Pharmaceutical Services to be Modestly Overvalued.

Key valuation signals for BSP:W2ST34:

  • Net Loan:
  • GF Value™: R$43.98 vs. price of R$51.25 (16.5% above fair value)
  • GF Score™: 24/100 with 4 warning signs

No single metric tells the full story. See the BSP:W2ST34 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


West Pharmaceutical Services Business Description

Address 530 Herman O. West Drive, Exton, PA, USA, 19341-1147
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
24GF Score

Get the complete analysis for BSP:W2ST34

Net Loan is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$51.25
Price
R$43.98
GF Value